A9 Tck as Therapeutic Targets
- Date:
- 1999-2007
- Reference:
- SA/KET/A/4/1/9
- Part of:
- The Kennedy Trust for Rheumatology Research
- Archives and manuscripts
About this work
Description
Item relates to patent A9 "Tck as Therapeutic Targets," invented by Marc Feldmann, Brian Foxwell and Fionula Brennan under applicant Synovis Ltd and The Kennedy Institute of Rheumatology. The patent is also referred to as "Therapeutic Methods and Compounds", "Tck Cells" and "Tck Inhibitors".
The item contains papers relating to the filing and prosecution progress for UK, International PCT, European, Canadian, US, Australian, Hong Kong and Japanese applications.
See related material for A9 Espacenet listing (includes patent abstract and digital copies of application).
Publication/Creation
1999-2007
Physical description
1 file (in 3 parts)
Related material
Terms of use
This item requires facilitated access. Email library@wellcomecollection.org to request an appointment.
Where to find it
Location Status Access Closed storesBy appointment Manual request